Levitra ODT - a new era in the treatment of erectile dysfunction
https://doi.org/10.14341/probl201359157-61
Abstract
References
1. McKinlay J.B. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000; 12: Suppl 4: S6-S11.
2. Montorsi F., Adaikan G., Becher E. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2010; 7: 11: 3572-3588.
3. Satis FACTS. Международный опрос. Байер ХелсКэр 2011.
4. Perelman M., Edwards D. Perceptions of Erectile Dysfunction Therapy and Acceptance of an Orodispersible Phosphodiesterase Type 5 Drug Formulation Among Patients and Physicians. J Mens Health 2010; 7: 3: 325.
5. Fu Y., Yang S., Jeong S.H., Kimura S., Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004; 21: 6: 433-476.
6. Leonardi R., Alemanni M. The management of erectile dysfunction: innovations and future perspectives. Arch Ital Urol Androl 2011; 83: 1: 60-62.
7. Debruyne F.M., Gittelman M., Sperling H., Börner M., Beneke M. Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations. J Sex Med 2011; 8: 10: 2912-2923.
8. Heinig R., Weimann B., Dietrich H., Böttcher M.F. Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials. Clin Drug Invest 2011; 31: 1: 27-41.
9. Sperling H., Gittelman M., Norenberg C., Ulbrich E., Ewald S. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials. J Sex Med 2011; 8: 1: 261-271.
10. Green R., Hicks R.W. Orally disintegrating vardenafil tablets for the treatment of erectile dysfunction: efficacy, safety, and patient acceptability. Patient Prefer Adher 2011; 5: 181-185.
11. Sperling H., Debruyne F., Boermans A., Beneke M., Ulbrich E., Ewald S. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. J Sex Med 2010; 7: 4: Pt 1: 1497-1507.
12. Gittelman M., McMahon C.G., Rodríguez-Rivera J.A., Beneke M., Ulbrich E., Ewald S. The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. Int J Clin Pract 2010; 64: 5: 594-603.
13. Sanford M. Orodispersible vardenafil tablet. Drugs 2012; 72: 1: 87-98.
Review
For citations:
Vertkin A.L., Morgunov L.I. Levitra ODT - a new era in the treatment of erectile dysfunction. Problems of Endocrinology. 2013;59(1):57-61. https://doi.org/10.14341/probl201359157-61
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
